Undervalued Biotech Analysis

This page is an archive of all the due diligence on this website.

Antimicrobial
Spero Therapeutics (SPRO) 13 October 2025

CNS
Cognition Therapeutics (CGTX) 20 September 2025

Gene Editing
Solid Bioscience (SLDB) 26 October 2025

Hepatology
Aligos Therapeutics (ALGS) 06 October 2025
Inventiva S.A. (IVA) 16 October 2025

Oncology
IN8bio (INAB) 20 November 2025


General Article
Price Action per Clinical Stages 25 November 2025
Rare Genetic Disease 05 November 2025
ADR Stock Warning 29 October 2025